The pathways in colorectal neoplasia can be broadly divided into: Examination of the targeted pathways including VEGF and EGF receptors is likely to provide predictive information for metastatic ...

Cemiplimab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Colorectal Cancer.

The following is a summary of “Current status of serum metabolites biomarkers for polyps and colorectal cancer: a systematic ...

Korean researchers have developed a technology that treats colon cancer by converting cancer cells into a state resembling ...

Scientists uncover how disrupted lipid metabolism fuels chronic inflammation in colorectal cancer, offering insights into new therapeutic strategies targeting pro-inflammatory and pro-resolving lipid ...

"In this study we show a mechanistic pathway from diet to colon cancer in an animal model," said corresponding author Dr.

Larotrectinib sulfate is under clinical development by Bayer and currently in Phase II for Colorectal Cancer. According to GlobalData, Phase II drugs for Colorectal Cancer have a 25% phase transition ...